Jazz Pharmaceuticals plc Acquisitions, Net of Cash Acquired
Jazz Pharmaceuticals plc (JAZZ) reported Acquisitions, Net of Cash Acquired of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2024-02-28
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for the quarter ending 2017-12-31 was $0.00.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for the quarter ending 2016-12-31 was $0.00.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for the quarter ending 2015-12-31 was $0.00.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for the quarter ending 2015-09-30 was $0.00.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for fiscal 2021 was $6.23B.
- Jazz Pharmaceuticals plc payments to acquire businesses, net of cash acquired for fiscal 2020 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2021-12-31 | $6.23B 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | |||
| 2018-12-31 | $0.00 10-K · filed 2019-02-26 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | ||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.50B 10-K · filed 2019-02-26 | ||
| 2016-09-30 | $1.50B 10-Q · filed 2017-11-07 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $0.00 derived: sum of 2 quarters · filed 2016-11-08 | $0.00 10-Q · filed 2016-11-08 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $828.68M 10-K · filed 2017-02-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $828.68M 10-Q · filed 2015-11-09 | $828.68M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $828.68M 10-Q · filed 2015-08-05 | $828.68M derived: sum of 3 quarters · filed 2016-02-23 | $828.68M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $828.68M 10-Q · filed 2015-05-07 | $828.68M derived: sum of 2 quarters · filed 2016-02-23 | $828.68M derived: sum of 3 quarters · filed 2016-02-23 | $828.68M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $0.00 derived: sum of 2 quarters · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $0.00 10-Q · filed 2014-08-05 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $624.28M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $624.28M derived: sum of 3 quarters · filed 2015-02-24 | $542.53M 10-K · filed 2015-02-24 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $624.28M derived: sum of 2 quarters · filed 2013-11-05 | $542.53M 10-Q · filed 2013-11-05 | $542.53M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $624.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $542.53M 10-Q · filed 2013-08-06 | $542.53M derived: sum of 3 quarters · filed 2014-02-25 | |
| 2012-03-31 | -$81.75M 10-Q · filed 2013-05-07 | -$81.75M derived: sum of 2 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $0.00 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-09 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |